NCT06261762

Brief Summary

The goal of this observational study is to evaluate the post-extraction hard and soft tissue dimension changes in patients requiring consecutive extractions and unassisted socket healing in the anterior maxilla. The main questions it aims to answer are:

  • Is significant alveolar ridge resorption observed at center sites after consecutive extractions
  • Is significant alveolar ridge resorption observed at the interalveolar septum after consecutive extractions, are different extraction sites associated with significantly different bone resorption
  • Is a thick or thin wall phenotype associated with the amount of bone resorption
  • Is soft tissue thickness change associated with the corresponding location (extraction site or interalveolar septum) and post-extraction thickness of the bone
  • Is the interdental papilla height significantly affected after extractions. Participants will undergo consecutive (two) extractions and will be evaluated after subsequent unassisted socket healing for 8 weeks.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
1mo left

Started Feb 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Feb 2024Jun 2026

First Submitted

Initial submission to the registry

February 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

February 29, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

2.3 years

First QC Date

February 7, 2024

Last Update Submit

February 7, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Bone level change from baseline

    Measured in millimeters using segmented surface model superimpositions. Changes in bone loss between baseline and an 8 week healing period using CBCT. From the Digital Imaging and Communications in Medicine (DICOM) files two surface mesh models were generated, which were superimposed and the changes were subsequently analyzed.

    Baseline and at 8 weeks

  • Soft tissue change from baseline

    Changes in soft tissue loss at baseline and 8 weeks were analyzed using digital dental impressions acquired from intraoral scans, which were superimposed and the changes were analyzed.

    Baseline and at 8 weeks

Secondary Outcomes (1)

  • Correlation between baseline facial bone thickness and dimensional soft tissue alterations during healing at the interalveolar septum.

    Baseline and at 8 weeks

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The group is selected from the referred patient pool. Age 18 or older. Absence of significant medical conditions. Sites with a need for consecutive (two) teeth extraction in the anterior maxilla.

You may qualify if:

  • + years old
  • Require consecutive (two) teeth replacement in the anterior maxilla
  • Signed informed consent
  • No significant medical conditions
  • Patients with healthy periodontal conditions or previously treated to controlled and stable conditions

You may not qualify if:

  • General medical (American Society of Anesthesiologists, ASA, class III or IV) and/or psychiatric contraindications
  • Pregnancy or nursing
  • Any interfering medication such as steroid therapy or bisphosphonate therapy
  • Uncontrolled diabetes
  • Autoimmune diseases or inflammatory diseases affecting the intraoral tissues
  • Radiation therapy to head or neck region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Feng Wang

    Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2024

First Posted

February 15, 2024

Study Start

February 29, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

February 15, 2024

Record last verified: 2024-02